Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Diversity & Inclusion Drug Development
Why Clinical Trial Success Criteria Matters: 5 Essential Questions
As the pharmaceutical and biotech industries continue to push for faster drug development, the importance of equity and diversity in clinical trial recruitment cannot be overlooked. With the rise of… Continue reading →

Read the article
no
Diversity & Inclusion Drug Development
Optimizing Clinical Data Registries: Opportunities for Diversity and Feasibility
In an October 2023 report, BMC Medicine completed a follow-up on a 10-year effort to understand, report on and track data sharing challenges with big pharma, specifically for clinical… Continue reading →

Read the article
no
Artificial Intelligence
Evaluating an AI Product in Life Sciences
The life sciences industry, characterized by stringent regulations, vast data sets, and the critical nature of its decisions, is increasingly turning to Artificial Intelligence (AI) for solutions. AI has the… Continue reading →

Read the article
no
KOL Engagement
Compliant Science: The Critical Role of Compliance for Medical Affairs
In medical affairs, building and managing relationships with key opinion leaders (KOLs) is a critical component of successful product launches and long-term growth. But in today’s highly regulated environment,… Continue reading →

Read the article
no
KOL Engagement
Boost HCP Access with a Unified Healthcare Data Platform
In an August 2022 market research study conducted by H1 and the Medical Science Liaison Society (MSLS), more than 600 MSLs surveyed weighed in on their experiences and preferences… Continue reading →

Read the article
no
Artificial Intelligence Drug Development
4 AI predictions for the Life Sciences Sector by 2025
The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. By 2025, we can anticipate pretty significant shifts… Continue reading →

Read the article
no

‹123 4 5 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕